thiotepa has been researched along with Chronic Kidney Failure in 1 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a patient with chronic renal failure and transitional cell carcinoma, in whom a nephrogenic adenoma of the bladder was diagnosed after a course of intravesical thiotepa treatment." | 7.68 | Nephrogenic adenoma in a patient with chronic renal failure associated with intravesical treatment with thiotepa. ( Embon, OM; Gold, CH; Sazbon, A; Turani, H, 1990) |
| "We describe a patient with chronic renal failure and transitional cell carcinoma, in whom a nephrogenic adenoma of the bladder was diagnosed after a course of intravesical thiotepa treatment." | 3.68 | Nephrogenic adenoma in a patient with chronic renal failure associated with intravesical treatment with thiotepa. ( Embon, OM; Gold, CH; Sazbon, A; Turani, H, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Embon, OM | 1 |
| Turani, H | 1 |
| Gold, CH | 1 |
| Sazbon, A | 1 |
1 other study available for thiotepa and Chronic Kidney Failure
| Article | Year |
|---|---|
Nephrogenic adenoma in a patient with chronic renal failure associated with intravesical treatment with thiotepa.
Topics: Adenoma; Administration, Intravesical; Carcinoma, Transitional Cell; Humans; Kidney Failure, Chronic | 1990 |